Evidence map›Paper›PMID 37502419›Full record

ArticleJournal of neuroendovascular therapy2021

Antiplatelet Loading Effects Prior to Endovascular Treatment: Carotid Artery Stenosis versus Unruptured Cerebral Aneurysms.

Kazumitsu Amari, Eriko Sugawara, Ryoo Yamamoto, Yu Amano, Masahiro Yamamoto, Ken Johkura

Abstract read
In one paragraph

Article in Journal of neuroendovascular therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kazumitsu AmariDepartment of Neuroendovascular Therapy, Yokohama Brain and Spine Center, Yokohama, Kanagawa, Japan.
Eriko SugawaraDepartment of Neurology, Yokohama Brain and Spine Center, Yokohama, Kanagawa, Japan.
Ryoo YamamotoDepartment of Neuroendovascular Therapy, Yokohama Brain and Spine Center, Yokohama, Kanagawa, Japan.
Yu AmanoDepartment of Neurology, Yokohama Brain and Spine Center, Yokohama, Kanagawa, Japan.
Masahiro YamamotoDepartment of Neurology, Yokohama Brain and Spine Center, Yokohama, Kanagawa, Japan.
Ken JohkuraDepartment of Neurology, Yokohama Brain and Spine Center, Yokohama, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Carotid artery stenosis and cerebral aneurism may have different platelet functions and antiplatelet responses because these diseases have different etiologies. In this study, we compared the antiplatelet loading effects prior to endovascular treatment between carotid artery stenosis and unruptured cerebral aneurysm (UCA) patients. Methods: Nine patients with asymptomatic carotid artery stenosis (ACS), 14 with symptomatic carotid artery stenosis (SCS), and 20 with unruptured cerebral aneurysms were enrolled in this study. Antiplatelet (aspirin + clopidogrel) loading effects prior to endovascular treatment were evaluated using light transmission aggregometry and platelet aggregate detection methods. Results: Although there are differences in the prevalence of atherosclerosis risk factors, maximum aggregation rates in light transmission aggregometry and platelet aggregation-prone properties were not different in the three disease groups. Conclusion: Preoperative dual antiplatelet therapy with aspirin and clopidogrel may be appropriate for both carotid artery stenosis and cerebral aneurism patients even though their conditions and background factors differ.

Indexed as

carotid artery stenosislight transmission aggregometryplatelet aggregateplatelet aggregationunruptured cerebral aneurysm

Identifiers

PMID37502419
PMCPMC10370956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.